cognitive cybersecurity intelligence

News and Analysis

Triple-Negative Breast Cancer Approach That Targets Translation Looks Promising

Researchers at Baylor College of Medicine discovered that the use of drug Zotatifin to target protein elF4A in testing on triple-negative breast cancer (TNBC) animal models suppressed tumour growth and improved the immune microenvironment of the tumour. These findings indicate a potential new avenue for TNBC treatment, with the possibility of clinical trials to assess patient benefits.

Source: –

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts

Flow Security Launches GenAI DLP

Flow Security, an Israel-based data security platform, has incorporated a GenAI DLP module to secure data for GenAI services and applications. The move seeks to